BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28383149)

  • 1. Anticancer Properties of Solamargine: A Systematic Review.
    Kalalinia F; Karimi-Sani I
    Phytother Res; 2017 Jun; 31(6):858-870. PubMed ID: 28383149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solamargine, a bioactive steroidal alkaloid isolated from Solanum aculeastrum induces non-selective cytotoxicity and P-glycoprotein inhibition.
    Burger T; Mokoka T; Fouché G; Steenkamp P; Steenkamp V; Cordier W
    BMC Complement Altern Med; 2018 May; 18(1):137. PubMed ID: 29720141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer activity evaluation of the solanum glycoalkaloid solamargine. Triggering apoptosis in human hepatoma cells.
    Kuo KW; Hsu SH; Li YP; Lin WL; Liu LF; Chang LC; Lin CC; Lin CN; Sheu HM
    Biochem Pharmacol; 2000 Dec; 60(12):1865-73. PubMed ID: 11108802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solamargine inhibits migration and invasion of human hepatocellular carcinoma cells through down-regulation of matrix metalloproteinases 2 and 9 expression and activity.
    Sani IK; Marashi SH; Kalalinia F
    Toxicol In Vitro; 2015 Aug; 29(5):893-900. PubMed ID: 25819016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis in human hepatoma SMMC-7721 cells by solamargine from Solanum nigrum L.
    Ding X; Zhu FS; Li M; Gao SG
    J Ethnopharmacol; 2012 Jan; 139(2):599-604. PubMed ID: 22172325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solamargine induces apoptosis and sensitizes breast cancer cells to cisplatin.
    Shiu LY; Chang LC; Liang CH; Huang YS; Sheu HM; Kuo KW
    Food Chem Toxicol; 2007 Nov; 45(11):2155-64. PubMed ID: 17619073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lysosomal-mitochondrial death pathway is induced by solamargine in human K562 leukemia cells.
    Sun L; Zhao Y; Li X; Yuan H; Cheng A; Lou H
    Toxicol In Vitro; 2010 Sep; 24(6):1504-11. PubMed ID: 20647040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solamargine inhibits gastric cancer progression by regulating the expression of lncNEAT1_2 via the MAPK signaling pathway.
    Fu R; Wang X; Hu Y; Du H; Dong B; Ao S; Zhang L; Sun Z; Zhang L; Lv G; Ji J
    Int J Oncol; 2019 May; 54(5):1545-1554. PubMed ID: 30864686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of AMPKα mediates additive effects of solamargine and metformin on suppressing MUC1 expression in castration-resistant prostate cancer cells.
    Xiang S; Zhang Q; Tang Q; Zheng F; Wu J; Yang L; Hann SS
    Sci Rep; 2016 Nov; 6():36721. PubMed ID: 27830724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Action of solamargine on TNFs and cisplatin-resistant human lung cancer cells.
    Liang CH; Liu LF; Shiu LY; Huang YS; Chang LC; Kuo KW
    Biochem Biophys Res Commun; 2004 Sep; 322(3):751-8. PubMed ID: 15336528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extraction, purification technology and antineoplastic effects of solamargine].
    Tang Z; Zhang Y; Li N; Xu L; Zhao B; Xiao W; Wang Z; Bi Y
    Zhongguo Zhong Yao Za Zhi; 2011 Aug; 36(16):2192-5. PubMed ID: 22097327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solamargine induces apoptosis associated with p53 transcription-dependent and transcription-independent pathways in human osteosarcoma U2OS cells.
    Li X; Zhao Y; Wu WK; Liu S; Cui M; Lou H
    Life Sci; 2011 Feb; 88(7-8):314-21. PubMed ID: 21163271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactive glycoalkaloides isolated from Solanum melongena fruit peels with potential anticancer properties against hepatocellular carcinoma cells.
    Fekry MI; Ezzat SM; Salama MM; Alshehri OY; Al-Abd AM
    Sci Rep; 2019 Feb; 9(1):1746. PubMed ID: 30741973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of solamargine in mouse melanoma model: relevance to clinical safety.
    Furtado RA; Ozelin SD; Ferreira NH; Miura BA; Almeida Junior S; Magalhães GM; Nassar EJ; Miranda MA; Bastos JK; Tavares DC
    J Toxicol Environ Health A; 2022 Feb; 85(4):131-142. PubMed ID: 34612163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting EP4 downstream c-Jun through ERK1/2-mediated reduction of DNMT1 reveals novel mechanism of solamargine-inhibited growth of lung cancer cells.
    Chen Y; Tang Q; Xiao Q; Yang L; Hann SS
    J Cell Mol Med; 2017 Feb; 21(2):222-233. PubMed ID: 27620163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solamargine upregulation of Fas, downregulation of HER2, and enhancement of cytotoxicity using epirubicin in NSCLC cells.
    Liang CH; Shiu LY; Chang LC; Sheu HM; Kuo KW
    Mol Nutr Food Res; 2007 Aug; 51(8):999-1005. PubMed ID: 17639997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solamargine purified from Solanum incanum Chinese herb triggers gene expression of human TNFR I which may lead to cell apoptosis.
    Hsu SH; Tsai TR; Lin CN; Yen MH; Kuo KW
    Biochem Biophys Res Commun; 1996 Dec; 229(1):1-5. PubMed ID: 8954074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solamargine induces apoptosis and enhances susceptibility to trastuzumab and epirubicin in breast cancer cells with low or high expression levels of HER2/neu.
    Shiu LY; Liang CH; Chang LC; Sheu HM; Tsai EM; Kuo KW
    Biosci Rep; 2009 Feb; 29(1):35-45. PubMed ID: 18699774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solamargine enhances HER2 expression and increases the susceptibility of human lung cancer H661 and H69 cells to trastuzumab and epirubicin.
    Liang CH; Shiu LY; Chang LC; Sheu HM; Tsai EM; Kuo KW
    Chem Res Toxicol; 2008 Feb; 21(2):393-9. PubMed ID: 18078328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of HER2/neu receptor by solamargine enhances anticancer drug-mediated cytotoxicity in breast cancer cells with high-expressing HER2/neu.
    Shiu LY; Liang CH; Huang YS; Sheu HM; Kuo KW
    Cell Biol Toxicol; 2008 Jan; 24(1):1-10. PubMed ID: 17885815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.